Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and 9,10-dimethyl-1,2-benzanthracene

rosiglitazone has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fischer, SM; He, G; Lubet, RA; Muga, S; Thuillier, P1
Gupta, J; Kumar, P; Tikoo, K1
Alakavuklar, M; Canda, T; Cehreli, R; Guner, G; Gurel, D; Kocdor, H; Kocdor, MA; Yilmaz, O1

Other Studies

3 other study(ies) available for rosiglitazone and 9,10-dimethyl-1,2-benzanthracene

ArticleYear
The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.
    Molecular carcinogenesis, 2005, Volume: 43, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Carcinogens; Cell Proliferation; Cell Transformation, Neoplastic; Chromans; Diet; Female; Keratinocytes; Ligands; Mice; PPAR gamma; RNA, Messenger; Rosiglitazone; Skin Neoplasms; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Ultraviolet Rays

2005
Rosiglitazone synergizes anticancer activity of cisplatin and reduces its nephrotoxicity in 7, 12-dimethyl benz{a}anthracene (DMBA) induced breast cancer rats.
    BMC cancer, 2009, Apr-08, Volume: 9

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Urea Nitrogen; Blotting, Western; Body Weight; Cisplatin; Creatinine; Drug Synergism; Enzyme-Linked Immunosorbent Assay; Histones; Kidney; Kidney Diseases; Mammary Glands, Animal; Mammary Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Phosphorylation; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Serum Albumin; Thiazolidinediones; Tumor Burden; Tumor Necrosis Factor-alpha

2009
Chemopreventive efficacies of rosiglitazone, fenretinide and their combination against rat mammary carcinogenesis.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2009, Volume: 11, Issue:4

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinogens; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Fenretinide; Hypoglycemic Agents; Insulin-Like Growth Factor I; Mammary Neoplasms, Experimental; Prolactin; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones

2009